TipRanks
Advertisement

QFRD - ETF AI Analysis

Compare

Top Page

QFRD

Pacer S&P 500 Quality FCF R&D Leaders (QFRD)

Rating:74Outperform
Price Target:―
QFRD’s rating reflects a portfolio led by high-quality growth names like Incyte, Cadence Design, and Vertex Pharmaceuticals, which show strong financial performance, solid profitability, and promising R&D-driven pipelines that support the fund’s quality and innovation focus. However, several major holdings such as Datadog, Palo Alto Networks, Synopsys, and Coinbase face high valuation, overbought or weak technical signals, and in some cases cash flow or expense concerns, which introduce risk and help explain why the fund’s rating is not higher, especially given its concentration in tech and R&D-heavy companies.
Positive Factors
Strong Recent Performance
The ETF has delivered solid gains so far this year and over the past three months, showing positive momentum.
High-Performing Growth Leaders
Several of the largest holdings, such as Datadog, AMD, CrowdStrike, and Palo Alto Networks, have shown strong year-to-date performance, helping drive the fund’s returns.
Focused on Innovative Sectors
Heavy exposure to technology and health care means the fund is tilted toward companies that invest in research and development and can benefit from long-term innovation trends.
Negative Factors
Sector Concentration Risk
With most of the portfolio in technology and health care, the ETF could be hit hard if these sectors fall out of favor.
Limited Geographic Diversification
Almost all assets are invested in U.S. companies, so the fund offers little protection if the U.S. market underperforms other regions.
Moderately High Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which means more of the returns are used to cover fees instead of going to investors.

QFRD Historical Chart

QFRD Summary

QFRD is an ETF that follows the S&P 500 Quality FCF R&D Leaders Index, focusing on about 50 large U.S. companies that spend heavily on research and development while also generating strong cash flow. It leans toward innovative sectors like technology and healthcare, with well-known names such as Advanced Micro Devices (AMD) and Electronic Arts (EA) in the mix. Investors might consider QFRD if they want growth potential from innovative companies while still emphasizing financially solid businesses. A key risk is that the fund is heavily tilted toward tech and healthcare, so its value can swing more than a broadly diversified market fund.
How much will it cost me?This ETF has an expense ratio of 0.49%, which means you’ll pay about $4.90 per year for every $1,000 you invest. That’s higher than the cost of a typical broad, passively managed S&P 500 index fund because this ETF tracks a more specialized index that focuses on a smaller group of R&D-focused, high-quality companies.
What would affect this ETF?QFRD could benefit if the U.S. economy stays resilient, tech and healthcare innovation remains strong, and lower interest rates or supportive regulations make it easier for its R&D‑heavy companies to grow and turn new ideas into profits. On the other hand, it could be hurt by rising interest rates that pressure growth stocks, tighter rules on big tech or digital assets, or a downturn that hits its concentrated U.S. technology and healthcare holdings harder than the broader market.

QFRD Top 10 Holdings

QFRD is leaning hard into U.S. innovation, with a tech-heavy lineup where Datadog, CrowdStrike, AMD, and Synopsys are doing most of the heavy lifting as they ride strong momentum in cloud, cybersecurity, and chips. Palo Alto Networks adds another sturdy cyber pillar, though its rich valuation could make the ride bumpier. On the softer side, Workday looks more like it’s catching its breath, and Coinbase has been a bit of a drag despite occasional bursts of energy. Overall, this is a concentrated bet on U.S. tech and healthcare R&D leaders rather than a broad market sampler.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Datadog6.64%$124.97K$103.16B76.12%
69
Neutral
CrowdStrike Holdings5.00%$94.16K$269.31B113.69%
67
Neutral
Advanced Micro Devices4.29%$80.82K$970.08B177.65%
73
Outperform
Palo Alto Networks4.08%$76.73K$330.33B91.28%
73
Outperform
Workday4.04%$76.05K$45.37B-21.57%
73
Outperform
Cadence Design3.24%$60.97K$95.95B2.59%
78
Outperform
Synopsys3.23%$60.80K$96.30B11.44%
73
Outperform
Incyte3.13%$58.91K$22.57B26.36%
81
Outperform
Vertex Pharmaceuticals2.94%$55.26K$128.50B17.71%
78
Outperform
Coinbase Global2.78%$52.31K$47.59B-46.77%
68
Neutral

QFRD Technical Analysis

Technical Analysis Sentiment
Positive
Last Price―
Price Trends
50DMA
30.03
Positive
100DMA
28.91
Positive
200DMA
Market Momentum
MACD
0.47
Positive
RSI
58.05
Neutral
STOCH
63.75
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For QFRD, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 30.86, equal to the 50-day MA of 30.03, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.47 indicates Positive momentum. The RSI at 58.05 is Neutral, neither overbought nor oversold. The STOCH value of 63.75 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for QFRD.

QFRD Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
――$1.88M0.49%
74
Outperform
――$93.24M1.00%
73
Outperform
――$92.16M0.80%
67
Neutral
――$87.87M0.09%
74
Outperform
――$84.11M0.93%
58
Neutral
――$83.73M0.60%
71
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
QFRD
Pacer S&P 500 Quality FCF R&D Leaders
31.16
6.62
26.98%
PRMR
PeakShares RMR Prime Equity ETF
―
―
―
FCUS
Pinnacle Focused Opportunities ETF
―
―
―
SPXE
ProShares S&P 500 Ex-Energy ETF
―
―
―
EGGQ
NestYield Visionary ETF
―
―
―
ALTL
Pacer Lunt Large Cap Alternator ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement